• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).

作者信息

Abellan van Kan G, Cderbaum J M, Cesari M, Dahinden P, Fariello R G, Fielding R A, Goodpaster B H, Hettwer S, Isaac M, Laurent D, Morley J E, Pahor M, Rooks D, Roubenoff R, Rutkove S B, Shaheen A, Vamvakas S, Vrijbloed J W, Vellas B

机构信息

Gerontopole Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, INSERM 1027, Toulouse, France.

出版信息

J Nutr Health Aging. 2011 Dec;15(10):834-46. doi: 10.1007/s12603-011-0365-1.

DOI:10.1007/s12603-011-0365-1
PMID:22159770
Abstract
摘要

相似文献

1
Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).肌肉减少症：生物标志物与影像学（肌肉减少症研究国际会议）
J Nutr Health Aging. 2011 Dec;15(10):834-46. doi: 10.1007/s12603-011-0365-1.
2
Plasma C-terminal agrin fragment concentrations across adulthood: Reference values and associations with skeletal muscle health.成年期血浆C末端聚集蛋白片段浓度：参考值及其与骨骼肌健康的关联。
J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1501-1510. doi: 10.1002/jcsm.13507. Epub 2024 Jun 7.
3
Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older multimorbid community-dwellers: Results from the ilSIRENTE study.血清C端集聚蛋白片段（CAF）水平与多病共存的老年社区居民肌肉减少症相关：来自ilSIRENTE研究的结果。
Exp Gerontol. 2016 Jun 15;79:31-6. doi: 10.1016/j.exger.2016.03.012. Epub 2016 Mar 23.
4
Sarcopenia: An Overview on Current Definitions, Diagnosis and Treatment.肌肉减少症：当前定义、诊断与治疗概述
Curr Protein Pept Sci. 2018 May 14;19(7):633-638. doi: 10.2174/1389203718666170607113459.
5
[Definition of sarcopenia and diagnostic evaluation in clinical practice].[临床实践中肌肉减少症的定义及诊断评估]
Rev Med Suisse. 2015 Mar 18;11(466):651-6.
6
Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia.骨骼肌质量与质量：在肌肉减少症背景下现代测量概念的演变
Proc Nutr Soc. 2015 Nov;74(4):355-66. doi: 10.1017/S0029665115000129. Epub 2015 Apr 8.
7
Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients.升高的 C 端神经胶质细胞衍生神经营养因子片段水平可识别出一类新的骨骼肌减少症患者亚群。
Exp Gerontol. 2013 Jan;48(1):69-75. doi: 10.1016/j.exger.2012.03.002. Epub 2012 Mar 11.
8
[Evolution of the concept of sarcopenia. Rehabilitation perspectives].[肌肉减少症概念的演变。康复前景]
Rehabilitacion (Madr). 2020 Apr-Jun;54(2):75-78. doi: 10.1016/j.rh.2020.01.002. Epub 2020 Mar 31.
9
Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia?在预测老年人与健康相关的结果方面，力量测量比肌肉量测量更具优势：是时候摒弃“肌肉减少症”这个术语了吗？
Osteoporos Int. 2017 Jan;28(1):59-70. doi: 10.1007/s00198-016-3691-7. Epub 2016 Jul 9.
10
Biomarkers for Sarcopenia: Reductionism vs. Complexity.肌肉减少症的生物标志物：还原论与复杂性
Curr Protein Pept Sci. 2018;19(7):639-642. doi: 10.2174/1389203718666170516115422.

引用本文的文献

1
Method of Forearm Muscles 3D Modeling Using Robotic Ultrasound Scanning.使用机器人超声扫描进行前臂肌肉三维建模的方法
Sensors (Basel). 2025 Apr 4;25(7):2298. doi: 10.3390/s25072298.
2
The effects of plantarflexor weakness and reduced tendon stiffness with aging on gait stability.随着年龄的增长，跖屈肌力量减弱和跟腱僵硬对步态稳定性的影响。
PLoS One. 2024 Apr 16;19(4):e0302021. doi: 10.1371/journal.pone.0302021. eCollection 2024.
3
Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis.肌肉减少症与心血管疾病：系统评价和荟萃分析。

本文引用的文献

1
Sarcopenia: designing phase IIB trials.肌肉减少症：设计 IIB 期临床试验。
J Nutr Health Aging. 2011 Jun;15(6):450-5. doi: 10.1007/s12603-011-0092-7.
2
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.肌肉减少症：老年人未被诊断的病症。当前共识定义：患病率、病因和后果。国际肌肉减少症工作组。
J Am Med Dir Assoc. 2011 May;12(4):249-56. doi: 10.1016/j.jamda.2011.01.003. Epub 2011 Mar 4.
3
Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia.
J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1183-1198. doi: 10.1002/jcsm.13221. Epub 2023 Apr 1.
4
Decrements of mobility and power in recreationally active septuagenarians is related to loss of force, but not slowing of the muscle: a 5-year longitudinal study.在经常参加娱乐活动的 70 多岁老年人中，运动能力和力量下降与力量损失有关，而与肌肉运动速度无关：一项为期 5 年的纵向研究。
Eur J Appl Physiol. 2023 Jun;123(6):1369-1379. doi: 10.1007/s00421-023-05160-0. Epub 2023 Feb 28.
5
Nutritional and Nutrition-Related Biomarkers as Prognostic Factors of Sarcopenia, and Their Role in Disease Progression.营养及营养相关生物标志物作为肌肉减少症的预后因素及其在疾病进展中的作用
Diseases. 2022 Jul 6;10(3):42. doi: 10.3390/diseases10030042.
6
Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008-2011.三酰甘油与葡萄糖指数与低肌肉量的相关性：2008-2011 年韩国国民健康营养调查。
Sci Rep. 2021 Jan 11;11(1):450. doi: 10.1038/s41598-020-80305-1.
7
Rehabilitation Strategies for Patients with Femoral Neck Fractures in Sarcopenia: A Narrative Review.肌少症患者股骨颈骨折的康复策略：一项叙述性综述
J Clin Med. 2020 Sep 26;9(10):3115. doi: 10.3390/jcm9103115.
8
Sarcopenia and sarcopenic obesity as prognostic predictors in hospitalized elderly patients with acute myocardial infarction.肌肉减少症和肌肉减少性肥胖作为老年急性心肌梗死住院患者的预后预测因素
Einstein (Sao Paulo). 2019 Aug 19;17(4):eAO4632. doi: 10.31744/einstein_journal/2019AO4632.
9
Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia.用于评估骨质疏松症和肌肉减少症的定量成像技术。
Quant Imaging Med Surg. 2018 Feb;8(1):60-85. doi: 10.21037/qims.2018.01.05.
10
Panoramic ultrasound: a novel and valid tool for monitoring change in muscle mass.全景超声：一种监测肌肉质量变化的新型有效工具。
J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):475-481. doi: 10.1002/jcsm.12172. Epub 2017 Jan 3.
关于治疗肌肉减少症的药物产品的有效治疗方法和治疗前景。
J Nutr Health Aging. 2009 Oct;13(8):746-56. doi: 10.1007/s12603-009-0209-4.
4
Validated treatments and therapeutic perspectives regarding physical activities.关于体育活动的有效治疗方法和治疗前景。
J Nutr Health Aging. 2009 Oct;13(8):742-5. doi: 10.1007/s12603-009-0208-5.
5
Validated treatments and therapeutic perspectives regarding nutritherapy.关于营养疗法的有效治疗方法和治疗前景。
J Nutr Health Aging. 2009 Oct;13(8):737-41. doi: 10.1007/s12603-009-0207-6.
6
What are the outcomes of treatment among patients with sarcopenia?肌肉减少症患者的治疗结果如何？
J Nutr Health Aging. 2009 Oct;13(8):733-6. doi: 10.1007/s12603-009-0206-7.
7
Target population for clinical trials.临床试验的目标人群。
J Nutr Health Aging. 2009 Oct;13(8):729-32. doi: 10.1007/s12603-009-0205-8.
8
Sarcopenia: clinical evaluation, biological markers and other evaluation tools.肌肉减少症：临床评估、生物标志物及其他评估工具
J Nutr Health Aging. 2009 Oct;13(8):724-8. doi: 10.1007/s12603-009-0204-9.
9
Physiopathological mechanism of sarcopenia.肌肉减少症的生理病理机制。
J Nutr Health Aging. 2009 Oct;13(8):717-23. doi: 10.1007/s12603-009-0203-x.
10
Towards a definition of sarcopenia--results from epidemiologic studies.关于肌肉减少症的定义——流行病学研究结果
J Nutr Health Aging. 2009 Oct;13(8):713-6. doi: 10.1007/s12603-009-0202-y.